| 词条 | Biohit |
| 释义 |
| name = Biohit Oyj | type = Julkinen osakeyhtiö | traded_as = {{OMX|HEX24241|BIOBV.B}} | founder = Osmo Suovaniemi | location = Helsinki, Finland | area_served = Worldwide | key_people = Osmo Suovaniemi (Founder and Chairman of the Board), Semi Korpela (President and CEO) | num_employees = about 419 | industry = Medical equipment | products = liquid handling equipment | equity = €23.9 million (2010) }} Biohit Oyj is a Finnish company which develops, manufactures, and markets diagnostics products for use in research and health care. SummaryBiohit was established in 1988 in Finland by Professor Osmo Suovaniemi (M.D., Ph.D.), previously known as the founder of Labsystems.[1][2] He stepped down from the CEO position in June 2011, but remains actively involved with the company through positions on several advisory boards. Biohit Oyj is a globally operating Finnish biotechnology company. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki since 1999, Small cap/Healthcare. Mr Semi Korpela was appointed CEO in 2011. MarketsBiohit's two businesses are acetaldehyde eliminating products and diagnostics. More than 90% of Biohit's sales occur outside Finland[3] Diagnostic tests The diagnostic product range of Biohit includes the GastroPanel examinations, which are used to aid diagnosis of Helicobacter pylori infection and atrophic gastritis from a blood sample. They are also ideal tools for identification of patients at increased risk of gastric cancer, peptic ulcer disease, gastroesophageal reflux disease (GERD) and deficiencies of vitamin B12, calcium and iron. In addition to this, Biohit offers Quick tests for the detection of •Lactose intolerance •Helicobacter pylori infection •Celiac disease •Screening of colorectal cancer Acetaldehyde binding products Monoclonal antibodies Biohit also develops and manufactures monoclonal antibodies for research use and use as raw materials for diagnostic industry. Instruments Adopting a systems approach, Biohit also provides laboratory equipment, such as microplate instruments and automates, as well as liquid handling products to support Biohit ELISA tests. Distribution NetworkA network of 40 distributors, including 2 subsidiaries, in more than 40 countries is selling Biohit products.{{Citation needed|date=January 2015}} Research, Development, and Intellectual PropertyBiohit spends roughly 30% of net sales on basic research each year and pursues an aggressive patenting strategy.[4] In 2014 Biohit started studies on migraine and cluster headache prevention with Acetium capsules.[5][6] References1. ^{{Cite journal |author = Harriet Öster |date = 8 October 1998 |title = Labsystems kasvaa suuren suojassa |journal = Tekniikka & Talous |url = http://www.tekniikkatalous.fi/uutiset/article28510.ece |accessdate = 2009-11-15 }} 2. ^{{Cite web |title=Aggressive Innovation and Patenting Strategy – the Way to Success and National Well-Being |author=Osmo Suovaniemi, Helena Hentola |publisher=Biohit |year=2004 |url=http://www.biohit.com/resource/files/media/articles/biohit-innovation-patenting-strategy.pdf }} 3. ^Biohit Oyj. Annual Report 2012 4. ^Reuters. Overview of Biomet Oyj. https://www.reuters.com/finance/stocks/companyProfile?rpc=66&symbol=BIOBV.HE 5. ^The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients https://clinicaltrials.gov/ct2/show/NCT02315833 6. ^The Efficacy of L-cysteine in Prevention of Cluster Headache https://clinicaltrials.gov/ct2/show/NCT02310828 4 : Companies established in 1988|Biotechnology companies of Finland|Chemical companies of Finland|Companies listed on the Helsinki Stock Exchange |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。